99% Savings - Buy Just @1 Rs X
Goodnoct XR 6.25 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Male) |
|
Adult(Female) |
|
Geriatric |
|
Is the use of Goodnoct XR 6.25 Tablet safe for pregnant women?
Goodnoct can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Goodnoct right away. Take your doctor's advice before taking it again.
Is the use of Goodnoct XR 6.25 Tablet safe during breastfeeding?
Goodnoct may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Goodnoct, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Goodnoct.
What is the effect of Goodnoct XR 6.25 Tablet on the Kidneys?
Using Goodnoct does not have any harmful effects on kidneys.
What is the effect of Goodnoct XR 6.25 Tablet on the Liver?
Goodnoct has very mild side effects on the liver.
What is the effect of Goodnoct XR 6.25 Tablet on the Heart?
Goodnoct is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Goodnoct XR 6.25 Tablet unless your doctor advises you to do so -
Is this Goodnoct XR 6.25 Tablet habit forming or addictive?
Goodnoct XR 6.25 Tablet can be addictive. You should not take it without medical advice.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Goodnoct XR 6.25 Tablet as you may feel sleepy.
Is it safe?
Goodnoct XR 6.25 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Goodnoct XR 6.25 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Goodnoct XR 6.25 Tablet
Taking Goodnoct XR 6.25 Tablet with food does not cause any problems.
Interaction between Alcohol and Goodnoct XR 6.25 Tablet
Consuming Goodnoct XR 6.25 Tablet with alcohol can have many serious effects on your body.
Goodnoct is a brand name of zolpidem and it comes in the form of a tablet. It is a prescription drug that belongs to the class of drug known as imidazopyridine (sedative & hypnotic). It is used for the treatment of insomnia (sleeplessness).
Goodnoct contains zolpidem which is a sedative & hypnotic agent. It is presumed that zolpidem works by producing the calming effect on the brain by decreasing the excessive neuronal activity of the brain which induces sleep.
Ideally, Goodnoct is given for the short-term management of insomnia. You are advised take it as per your doctor's advice. Do not take it longer than prescribed by your doctor to avoid unpleasant side effects.
No, Goodnoct is not addictive but it can lead to dependency if taken in higher doses for the longer duration. Since Goodnoct is prescribed for the short-duration treatment of insomnia, you are advised not to take in more than the recommended doses and for a longer duration to avoid dependency on this drug for inducing sleep.
Yes, Goodnoct is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as dizziness, lack of energy, and rash. If you experience above-mentioned side effects after taking this medicine then inform your doctor and follow his/her instructions.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ambien® (zolpidem tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 406-407
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1296-1298